Setting the standard in hysteroscopic tissue removal

More than 10 years of clinical experience

Featuring fast1, efficient resection, advanced fluid management and pathology optimized tissue removal devices, the TruClear™ system offers a complete technology platform for the removal of a range of intrauterine abnormalities.



“With the TruClear system, I can address a wide spectrum of abnormalities with one high-performing system.” - Dr. Charles E. Miller, Advocate Lutheran General Hospital, Park Ridge, IL


As the only pathology-optimized, hysteroscopic tissue removal system, the TruClear™ system enables more efficient1 procedures and enhanced performance for a full spectrum of conditions, including:


  • Polypectomy

    The TruClear™ System:

    • May improve the efficiency of polyp removal by reducing polypectomy procedure time by half2 that of electrical resection
    • Is more likely to completely remove polyps compared to electrical resection1
    • Offers unimpeded access to all pathology within the cavity and resects polyps down to the base
    • Minimizes patient discomfort because of small scope diameters
    • Allows the treatment to be conducted in outpatient clinic with no or only local anesthesia
  • Myomectomy

    The TruClear™ System:

    • Brings speed, efficiency and precision to the removal of intrauterine myomas
    • Helps ensure patient safety through advanced fluid management
    • Reduces the risk of traumatic injury to the uterus3
    • In trials assessing the efficacy of the TruClear™ system, on average 97% of endometrial polyps and 90% of uterine fibroids were successfully removed on first attempt1,2,4-6
    • Hysteroscopic removal of these pathologies has been shown to provide substantial to significant improvement in patient quality of life7-8
  • Retained Products of Conception Evacuation

    The TruClear™ System:

    • Minimizes endometrial damage by evacuating RPOC under direct visualization
    • Captures tissue for histological confirmation
    • Potentially reduces the need for additional procedures as the system has demonstrated complete removal in over 94% of patients5
  • 1. Smith, PP, MBChB; Middleton, LJ, MSc; Connor, M, MD and Clark, TJ, MD (2014). Hysteroscopic Morcellation Compared With Electrical Resection of Endometrial Polyps.(2014). Obstetrics & Gynecology, 123(4), 745-751.

  • 2. Emanuel, M.H., and Wamsteker, K. (2005). “The Intra Uterine Morcellator: A New Hysteroscopic Operating Technique to Remove Intrauterine Polyps and Myomas.” TheJournal of Minimally Invasive Gynecology 12(1), 62-66.

  • 3. NICE. Hysteroscopic morcellation of uterine leiomyomas (fibroids). 2015:1-9.

  • 4. van Dongen H, Emanuel MH, Wolterbeek R, Trimbos JB, Jansen FW. Hysteroscopic morcellator for removal of intrauterine polyps and myomas: a randomized controlled pilot study among residents in training. J Minim Invasive Gynecol. 2008;15(4):466-471.

  • 5. Hamerlynck, TWO, MD; Blikkendaal, MD, MD; Schoot, BC, MD, PhD; Hanstede, MMF, MDand Jansen, FW, MD, PhD. (2013). “An Alternative Approach for Removal of PlacentalRemnants: Hysteroscopic Morcellation.” JMIG December 2013 20(6), 796-802.

  • 6. Pampalona JR, Bastos MD, Moreno GM, et al. A comparison of hysteroscopic mechanical tissue removal with bipolar electrical resection for the management of endometrial polyps in an ambulatory care setting: preliminary results. J Minim Invasive Gynecol. 2015;22(3):439-445.

  • 7. Cooper N a. M, Clark TJ, Middleton L, et al. Outpatient versus inpatient uterine polyp treatment for abnormal uterine bleeding: randomised controlled non-inferiority study. Bmj. 2015;350(mar23 6):h1398-h1398.

  • 8. Clark TJ, Middleton LJ, Cooper NA, et al. A randomised controlled trial of outpatient versus inpatient polyp treatment(OPT) for abnormal uterine bleeding. Health Technol Assess (Rockv). 2015;19(61):1-194.